Centiva Capital’s Boston Scientific BSX Stock Holding History

Centiva Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-40,000	Closed	-$2.74M	–	2085
2024 Q1	$2.74M	Sell	40,000 -20,000	-33%	-$1.29M	0.07%	229
2023 Q4	$3.47M	Buy	60,000 +40,000	+200%	+$2.14M	0.08%	229
2023 Q3	$1.06M	Sell	20,000 -15,600	-44%	-$818K	0.02%	610
2023 Q2	$1.93M	Hold	35,600	–	–	0.04%	397
2023 Q1	$1.78M	Buy	+35,600	New	+$1.68M	0.04%	430

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Centiva Capital's BSX Position: Q2 2026 in Review

Centiva Capital increased its Boston Scientific (BSX) stake by 315% in Q2 2026, buying an estimated $6.19M and bringing the position to 150,288 shares worth $6.41M. The position accounts for 0.06% of the portfolio, ranked #232.

Centiva Capital first reported a position in BSX in Q3 2019 and has held it in 15 quarters since. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Centiva Capital held 150,288 shares of Boston Scientific worth $6.41M as of Q2 2026.
Centiva Capital bought 114,037 Boston Scientific shares in Q2 2026, an estimated $6.19M.
Boston Scientific made up 0.06% of Centiva Capital's portfolio in Q2 2026, its #232 holding.
Centiva Capital first reported a position in Boston Scientific in Q3 2019 and has held it in 15 quarters since.
1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.